Lian Brian's Form 4 filing
Viking Therapeutics, Inc. (VKTX) · filed Feb 8, 2024
- Accession no.
- 0001209191-24-003010
- Filed
- Feb 8, 2024
- Trade date
- Feb 8, 2024
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 3 derivative transactions. Open-market sales total $7.23M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lian BrianCIK 0001614578 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 8, 2024 | Common Stock, par value $0.00001 per share | MOption exerciseAcquired | +49,079 | $1.23 | +$60,367.17 | 2,313,961 | Direct | |
| Feb 8, 2024 | Common Stock, par value $0.00001 per share | SSaleDisposed | −49,079 | $25.75 | −$1,263,784.25 | 2,264,882 | Direct | |
| Feb 8, 2024 | Common Stock, par value $0.00001 per share | MOption exerciseAcquired | +140,000 | $4.65 | +$651,000 | 2,404,882 | Direct | |
| Feb 8, 2024 | Common Stock, par value $0.00001 per share | SSaleDisposed | −60,000 | $25.95 | −$1,557,000 | 2,344,882 | Direct | |
| Feb 8, 2024 | Common Stock, par value $0.00001 per share | SSaleDisposed | −80,000 | $26.95 | −$2,156,000 | 2,264,882 | Direct | |
| Feb 8, 2024 | Common Stock, par value $0.00001 per share | SSaleDisposed | −40,000 | $27.45 | −$1,098,000 | 2,224,882 | Direct | |
| Feb 8, 2024 | Common Stock, par value $0.00001 per share | SSaleDisposed | −40,000 | $28.90 | −$1,156,000 | 2,184,882 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 8, 2024 | Common Stock | MOption exerciseDisposed | −14,148 | $0.00 | $0 | 0 | Direct | |
| Feb 8, 2024 | Common Stock | MOption exerciseDisposed | −34,931 | $0.00 | $0 | 0 | Direct | |
| Feb 8, 2024 | Common Stock | MOption exerciseDisposed | −140,000 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.